OK, I have had a chance to review questions I have received

New Post Public Reply Private Reply Replies (1) Message Board
patientgal
OK, I have had a chance to review questions I have received here and elsewhere. Since I am presently lacking the brain power required to even look at the board "elsewhere" right now, I am going to try to offer what I hope to be a clarification that makes sense and allays concerns of some. I will start by pasting a PM response to a very much invested BMSN buyer:

They did not resubmit the application. They received questions from the FDA and answered those questions. They then received a request for more data on the efficacy. They submitted this data sometime between receipt of the request (28 June) and 17 July when I spoke to Dr. Ichim and he confirmed that they had submitted the required information to the FDA for the SECOND round of questions. We do not know when the data was submitted OR if the FDA had already established with Regen during the course of the first Q&A if they, Regen, are required to WAIT for additional responses or could proceed with trials if nothing after 30 days.

You are missing key points here: there was a second round of questions to which data was supplied sometime after 28 June and before 17 July. Since the data provided required 14 days to confirm the determination one HAS to assume a new study was conducted since Koos was specific when he indicated data was GENERATED.

Key point #2: WE DO NOT KNOW IF THERE WAS A PROVISO established during part 1 of Q&A that dictated that Regen MUST wait for confirmation from the FDA after they have received/reviewed the responses to their questions.

I do not wish to seem bitchy, but fact is we do not know when we should expect a definitive response from Regen. Now, most of us are proficient enough with math that we can count back and speculate. But only Regen knows if they in fact were slapped with a proviso and if they received confirmation by the FDA that they have the FDA's blessing to move forward on Friday. Or, if they will receive it tomorrow.

If a proviso was not established, then most of us know enough based on the dd provided in the recent past that initiation of trials can start anytime if we consider that the "generated" dated was most likely submitted somewhere around 5 July (basing this on the 14 day time period required to generate the requested data.

Again, I appeal to you that you understand that we are not dealing with gold digging holding companies or yacht fleets. We are contending with the FDA and a protocol that is so convoluted and so extensive that if you spent every moment of every evening trying to familiarize yourself with the psychology or keep abreast of the constant changes, you would eventually find yourself running naked down the street screaming incoherently some twisted nursery rhyme from your youth!

This is not a get rich quick scheme. There is so much that the general public does not know. Nor will they ever know. What you should take comfort in however is the fact that you are invested in a company that although they have not been communication friendly with the masses (and that especially includes those of us that have financed their endeavors) they have been as transparent as any company can be from a legal standpoint and that they are quite literally creating , not attempting to create mind you, but creating cures for various types of CANCER!

RIVULET MEDIA INC. (RIVU) Stock Research Links

RIVU Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Workers Are Burning Savings as Pay Falls Behind Costs

Updated Category News Views 47

Payroll optimism has been ground into dust by the ordinary bills nobody can dodge. Monster's 2026 Cost of Living Report says 93% of employed U.S. workers feel their wages are failing to keep up with costs, barely different from 95% in both 2024 and 2025. That is not a blip, and it is not workers merely grousing about prices. Three years of nearly identical frustration...

Continue Reading
Cedars-Sinai and nference Build a Living Data Engine

Updated Category News Views 151

Five million patient histories are not a flashy product demo. They are a serious raw-material advantage, provided the data can be protected, organized, and made useful without turning clinical research into a carnival of loose claims. That is the real weight behind nference's long-term collaboration with Cedars-Sinai, announced November 20, 2026. The pair plan to build a...

Continue Reading
Northgate’s Stanton Opening Puts Community Work First

Updated Category News Views 75

A 55,721-square-foot grocery opening can look like ordinary retail churn until you notice where the money and attention are landing. Northgate González Market’s new Stanton location arrives ahead of Thanksgiving, yes, but the more telling detail is the company’s decision to pair a major store launch with 375 jobs and more than $30,000 directed toward families,...

Continue Reading
RingConn Bets Middle-earth Fandom Can Boost Health Wearables

Updated Category News Views 102

A Familiar Gold Band Meets a Crowded Wearables Market RingConn has taken one of pop culture's most loaded objects and turned it into a health-tracking accessory, which is either clever brand work or a costly bit of cosplay depending on execution. The company unveiled The One Ring, a limited-edition version of its Gen 3 Smart Ring, through a partnership with Warner Bros....

Continue Reading
Anduin Opens Its Investor Portal Beyond Early Users

Updated Category News Views 68

Private-market paperwork has long been a swamp of portals, PDFs, email chains, and somebody chasing down a wire change at the worst possible moment. Anduin is taking a swing at that mess by opening its Investor Portal to all customers after building it with leading asset managers and operating it with their investors. The pitch is sensible: give limited partners one...

Continue Reading
Rosenblatt Book Puts Vegas Casino Blind Spots on Display

Updated Category News Views 143

A locked casino floor is supposed to make secrets expensive. That is why the pitch behind ROSENBLATT lands with a little more weight than the usual Vegas chest-thumping: the coming memoir says Darryl Rosenblatt became a million-dollar gambler while using none of his own money, and that casino operators did not grasp the full shape of what had happened for years. Take a...

Continue Reading
NTN Data Breach Raises Hard Questions Beyond Lawsuit

Updated Category News Views 124

Paperwork lifted from a factory network can become a very expensive loose bolt. NTN Bearing Corporation of America, a U.S. maker of bearings and automotive components, has reported a data-security incident that may have exposed sensitive information belonging to current and former employees. A law firm, Edelson Lechtzin LLP, is investigating potential class-action claims....

Continue Reading
CVS Puts Youth Soccer Stories on Its Store Shelves

Updated Category News Views 60

Two kids with real community ties just got a megaphone most grown-ups never receive. CVS Pharmacy has named Caroline, 9, of Holmes Beach, Florida, and Zoe, 12, of Los Angeles, as the first grand-prize winners of its Home Team Heroes youth soccer contest. Each player’s selected nonprofit soccer organization will receive a $25,000 grant, while their stories will appear on...

Continue Reading
Digital Diabetes Care Has a Bigger Prize Than Devices

Updated Category News Views 121

A glucose sensor is becoming less a gadget than a running conversation between patient, clinician and software. That shift matters because diabetes management is leaving the occasional clinic visit and moving into daily life, where the useful product is not merely a reading but a pattern someone can act on. The sector deserves attention from investors, but it also...

Continue Reading
Midterm Voters Put Cost Relief Ahead of Washington Wars

Updated Category News Views 78

Gas pumps and medical bills have a way of humiliating every grand political slogan ever printed. Seven Letter Insight's latest post-election survey says confirmed 2026 midterm voters want the 120th Congress to deal with costs first, particularly gas prices, health care, restoring health care tax credits and energy bills. That is not a glamorous mandate. It is, however,...

Continue Reading

Top 5 Most Recently Viewed Articles

Allstream Insiders Unveils Industry Talks for Energy Pros

Updated Category News Views 294

Allstream Insiders Launches New Industry Talks Platform HOUSTON -- Allstream Insiders has rolled out an innovative platform called Industry Talks, specifically tailored for professionals within the energy sector. This initiative is designed to offer vital insights and a venue for sharing ideas that resonate in the New Energy markets. Focus on Career Growth and Skills A...

Continue Reading
Exploring Orexo's Pharmaceutical Innovations and IP Strategies

Updated Category News Views 130

Orexo's Insights on Pharmaceutical IP Strategies Orexo, a prominent player in the pharmaceutical industry, is poised to share its extensive knowledge in protecting intellectual property (IP) during an upcoming seminar. This event, organized in collaboration with esteemed law firms Potter Clarkson LLP and Steptoe LLP, aims to equip pharmaceutical companies, biotech firms,...

Continue Reading
Lindblad Expeditions Holdings Plans Tender Offer for Notes

Updated Category News Views 156

Lindblad Expeditions Holdings Begins Tender Offer for Senior Notes Lindblad Expeditions Holdings, Inc. (NASDAQ: LIND) has recently announced the pricing terms of its ongoing tender offer aimed at acquiring any and all of its outstanding 6.750% Senior Secured Notes due 2027. This notable initiative is executed through its wholly-owned subsidiary, Lindblad Expeditions, LLC....

Continue Reading
Key Economic Reports to Influence Markets This Thursday

Updated Category News Views 103

Key Economic Reports to Influence Markets This Thursday As traders gear up for another pivotal day in the financial markets, several key economic reports are expected to be released. These reports could significantly impact market dynamics and sway investor sentiment. This Thursday’s lineup includes essential data on the services sector, jobless claims, and factory...

Continue Reading
Investigation Launch: Zeta Global Holdings Corp Under Scrutiny

Updated Category News Views 160

Zeta Global Holdings Corp (NYSE: ZETA) is stepping into turbulent waters with an intense investigation hovering over its officers and directors regarding possible breaches of fiduciary duty. For shareholders who’ve been riding the wave since at least February 2022, this isn’t just another corporate footnote; it’s a pressing signal that deserves attention. With the...

Continue Reading